Clinical Trial Update: Maimonides Minocycline in Stroke Study [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 trial evaluating minocycline for acute ischemic and hemorrhagic stroke conducted by Maimonides Medical Center was terminated; results were posted on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemorrhagic Stroke
• Stroke

Drugs mentioned

• Minocycline (minocycline)

Snippet

Sponsor: Maimonides Medical Center | Conditions: Stroke, Acute, Ischemic Stroke | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2025-12-17